Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

2011 Russell Varian Prize for Innovation in Nuclear Magnetic Resonance

Published: Friday, September 30, 2011
Last Updated: Friday, September 30, 2011
Bookmark and Share
Agilent Technologies Inc. announces Gareth Alun Morris, professor of physical chemistry at the University of Manchester, as the winner of the 2011 Russell Varian Prize.

The prize is awarded to a researcher based on a single innovative contribution proven to have a significant impact on state-of-the-art nuclear magnetic resonance (NMR) technology. Morris was awarded this year’s prize for his seminal paper, “Enhancement of Nuclear Magnetic Resonance Signals by Polarization Transfer,” published in 1979 in the Journal of the American Chemical Society.

“The Russell Varian Prize is one of the highest accolades that the international NMR community can bestow,” said Morris. “The list of former recipients contains some of the most distinguished names in physics and chemistry, to whom I have looked up throughout my research career, and it is a great and a most unexpected honor to join them.”

The professor’s work provided the basis for the development of insensitive nuclear enhancement by polarization transfer (INEPT), which was originally devised for signal enhancement in liquid state NMR of insensitive nuclei such as carbon-13 and nitrogen-15, by broadband polarization transfer from proton spins. Since its inception, INEPT has evolved into a major component of modern multidimensional NMR techniques, with applications in liquids, liquid crystals and solids. The impact of INEPT has made it an indispensable component of the NMR toolkit.
Morris’s contributions to the knowledge of NMR techniques include more than 180 publications on the topic, and his laboratory continues to refine NMR methods to assist researchers in the fields of chemistry, biochemistry and medicine.

“We are pleased to recognize professor Morris for his significant scientific contributions to the field of NMR, enabling scientists in laboratories around the world to improve the intensity of signals for their chemical and biochemical analysis,” said Regina Schuck, Ph.D., general manager of Agilent’s Research Products Division.

The Russell Varian prize honors the memory of the pioneer behind the first commercial nuclear magnetic resonance spectrometers and co-founder of Varian Associates. The company was later purchased by Agilent.

“The Russell Varian Prize has a long tradition of recognizing the best innovators and researchers in NMR,” said Schuck. “Now a part of Agilent Technologies, we look forward to continuing the tradition of recognizing the top researchers around the world.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Presents Thought Leader Award to Renowned Medicinal Scientist
Company has announced that Dr. Shilin Chen has received an Agilent Thought Leader Award in support of his groundbreaking herbal genomics research using multi-omics techniques.
Saturday, April 30, 2016
Agilent Technologies Introduces First Commercial Software
Company has introduced new software to help cancer researchers in metabolic flux analysis.
Tuesday, April 19, 2016
Agilent, ASI Announce Agreement
Company has announced co-marketing agreement with ASI for fluorescence in situ hybridization.
Friday, April 08, 2016
Agilent Technologies and Eurofins Genomics Collaborate
Company has announced collaboration with Eurofins Genomics to expand SureVector cloning system.
Tuesday, March 22, 2016
Agilent Technologies to Sponsor USCAP 2016
Company has announced that it will be a Silver sponsor of USCAP 2016, the annual gathering of the United States and Canadian Academy of Pathology.
Thursday, March 10, 2016
Agilent Names CNAG as Certified Provider of Target-Enrichment Services
Centro Nacional de Análisis Genómico (CNAG) in Barcelona is one of Europe’s leading genome analysis centers.
Monday, February 23, 2015
Agilent to Close NMR Business
The announcement is part of Agilent's strategy to address the business shortfalls of its Research Products Division.
Wednesday, October 15, 2014
Agilent Technologies, University of Toronto to Collaborate on Metabolomics MRM Library-Software Solution
Scientists will be provided with a robust LC/MS solution to accelerate cell biology, disease research.
Tuesday, September 30, 2014
Agilent, Seoul National University to Collaborate on New Research Center
The facility will support new drug development center in the university's college of pharmacy.
Tuesday, May 13, 2014
Agilent Introduces Enhanced Electronic Laboratory Notebook
OpenLAB ELN integrates scientific results from multiple analytical software applications, quickly and easily.
Tuesday, November 19, 2013
Agilent and Daegu Gyeongbuk Institute of Science and Technology Collaborate
Neurometabolomics Center will use Agilent's bio-analytical instruments in research of biomarkers for early detection and diagnosis of brain diseases.
Friday, November 01, 2013
Agilent Combines Its Life Sciences and Diagnostics Businesses
Decision follows Agilent's announcement that it plans to separate the company into two independent publicly traded companies.
Thursday, September 19, 2013
Agilent to Acquire Assets from ABC Instrumentación Analítica
The companies have signed a definitive agreement for Agilent to acquire assets from the privately held Mexican distributor.
Thursday, September 05, 2013
Agilent Reports Third-Quarter Results
Revenues were $1.65 billion for the third fiscal quarter ended July 31, 2013, down 4 percent over one year ago.
Thursday, August 15, 2013
Agilent Technologies Triple Quadrupole ICP-MS Selected for R&D 100 Award
These prestigious awards recognize the 100 most technologically significant products introduced into the marketplace over the past year.
Monday, July 15, 2013
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!